ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 135 filers reported holding ROYALTY PHARMA PLC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,107,044 | -52.4% | 298,712 | -46.1% | 1.89% | -53.3% |
| Q2 2023 | $17,021,261 | -18.4% | 553,717 | -4.3% | 4.04% | -26.0% |
| Q1 2023 | $20,853,551 | -13.4% | 578,783 | -5.0% | 5.46% | -22.0% |
| Q4 2022 | $24,081,591 | -4.7% | 609,352 | -3.1% | 7.00% | -2.5% |
| Q3 2022 | $25,269,000 | -14.1% | 628,902 | -10.2% | 7.18% | -15.6% |
| Q2 2022 | $29,431,000 | +4.4% | 700,071 | -3.2% | 8.50% | +36.1% |
| Q1 2022 | $28,178,000 | -3.0% | 723,250 | -0.8% | 6.25% | +6.6% |
| Q4 2021 | $29,056,000 | +2.4% | 729,125 | -7.1% | 5.86% | -4.9% |
| Q3 2021 | $28,375,000 | -8.6% | 785,132 | +3.7% | 6.16% | -5.0% |
| Q2 2021 | $31,034,000 | -7.7% | 757,121 | -1.8% | 6.49% | -13.3% |
| Q1 2021 | $33,638,000 | -13.7% | 771,155 | -0.9% | 7.48% | -21.3% |
| Q4 2020 | $38,964,000 | +759.6% | 778,511 | +622.5% | 9.50% | +808.7% |
| Q3 2020 | $4,533,000 | – | 107,752 | – | 1.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |